Cann Group shares suspended as auditor reports ‘insufficient evidence’ of future funding by Steve Jones March 1, 2024March 1, 2024 Cann Group has been suspended from trading on the ASX after an independent auditor said there […]
No imported products tested since new GMP rules came into force, TGA admits, as MCIA calls for meeting by Steve Jones February 29, 2024February 29, 2024
Illicit medical users turning to legal pathways, new data reveals, as support for legalisation grows by Steve Jones February 29, 2024February 29, 2024
Wait goes on for Cann Global investors but firm insists deal ‘in final stages’ by Steve Jones February 28, 2024February 28, 2024
Vitura looks to combat price war with further expansion ‘beyond medicinal cannabis’ by Steve Jones February 28, 2024February 28, 2024
Medibis embarks on fresh capital raise ahead of autism clinical trial by Steve Jones February 23, 2024February 28, 2024
We’ll bring innovation and research to Australia, says Charlotte’s Web co-founder as products prepare to launch by Steve Jones February 22, 2024February 22, 2024
ECS Botanics chases in-house product growth after A$4m capital raise by Steve Jones February 22, 2024February 22, 2024
Industry in the spotlight as regulators unite to explore rise in prescriptions by Steve Jones February 22, 2024February 22, 2024
